INMD Stock Draws Investor Attention On Q4 Financial Update
The company said it anticipated its fourth-quarter (Q4) sales to fall within a tight range of $103.6 million to $103.8 million, compared with the analyst consensus estimate of $104.64 million, according to FiscalAI data.
Stocktwits·9d ago
Do Wall Street Analysts Like West Pharmaceutical Services Stock?
West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound.